Clinical Trials Sponsored by Global Fund

Total 3095 results

University of Oxford
Global Fund

Completed

Study to Assess Efficacy of Artemether-lumefantrine Prophylaxis Against Forest Malaria in Cambodia (PAL_Cambodia) (PAL_Cambodia)

Malaria

Cambodia
Johns Hopkins University
Global Fund; National Tuberculosis Control Program, Pakistan

Completed

A Controlled Smoking Cessation Trial and Prospective Cohort Study of Tuberculosis (TB) Treatment Outcomes

Smoking Cessation | Tuberculosis

Pakistan
Centre de Recherche Médicale de Lambaréné
Global Health Innovative Technology Fund

Not yet recruiting

Pan-Malaria Transmission-Blocking Vaccine AnAPN1 (PamTBVac)

Malaria

Gabon
Institut de Recherche pour le Developpement
Ministry of Health, Thailand; Global Fund

Completed

Observational Cohort of HIV Infected Adults and Children in the PHPT Network Hospitals in Thailand

HIV Infections

Thailand
Zentrum fuer Zahn-, Mund- und Kieferheilkunde

Unknown

White Blood Cell Signaling and Defense Mechanisms in Patients With Diabetes Mellitus Type 2 and Periodontitis (DMS)

Diabetes Mellitus, Type 2 | Chronic Periodontitis

Germany
Global D

Recruiting

Study Evaluating the Performance and Safety of Global D Implants Indicated for Trauma Surgery (CMF-TRAUMA)

Trauma Injury | Maxillofacial Trauma | Maxilla Fracture

France
RLS Global

Terminated

Evaluate Efficacy and Safety of ChloraSolv When Treating Pressure Ulcers in Need of Debridement

Pressure Ulcer

Sweden, United Kingdom, Aland Islands
Global BioClinical

Withdrawn

Prospective Collection of Surplus Surgical Tumor Tissues and Pre-surgical Blood Samples (GBCPRT0008)

Breast Cancer | Colorectal Cancer | Lung Cancer | Prostate Cancer | Hematologic Cancer

United States
Global Biotech

Completed

Safety Study of a Recombinant Human Plasminogen Activator to Treat Acute Ischemic Stroke.

Cerebrovascular Accident

Taiwan
Interactive Research and Development
Abdul Latif Jameel Poverty Action Lab; Global Innovation Fund

Completed

Evaluation of Conditional Cash Transfers (CCTs) for Immunization

Immunization; Infection

Pakistan
Global D

Recruiting

Study Evaluating the Performance and Safety in the Medium and Long Term of Global D Implant-prosthetic Systems

Dental Implants

France, Greece
RLS Global

Terminated

A PMCF Investigation on Chronic LU and DFU in Need of Debridement With ChloraSolv® (ChloraSolv02)

Chronic Diabetic Foot Ulcer | Chronic Leg Ulcer

Sweden
Global D

Active, not recruiting

Study Evaluating the Performance and Safety of Global D Implants Indicated for Orthognathic Surgery (CMF-ORTHO)

Maxillofacial Abnormalities | Orthognathic Surgery | Maxilla Fracture

France
RLS Global

Completed

An Open, Single-arm, Multi Centre Pilot Investigation to Evaluate the Debriding Effect of ChloraSolv® on Chronic Wounds

Chronic Ulcer at Lower Leg

Sweden
Global BioClinical

Withdrawn

Collection of Retrospective (Archival) Samples and Prospective Collection of Surplus Tissue and Blood Samples (GBCPRT0009)

Cancer

United States
University of Cape Town
World Health Organization; Medical Research Council, South Africa; Global Fund

Completed

Combination Antimalarials in Uncomplicated Malaria

Malaria

Mozambique, South Africa, Swaziland
University of Cape Town
World Health Organization; Medical Research Council, South Africa; Global Fund

Completed

A Randomised Efficacy Study of Combination Antimalarials to Treat Uncomplicated Malaria

Malaria

Mozambique
Stanford University
Government of Tamil Nadu; Global Innovation Fund; National AIDS Research Institute and other collaborators

Withdrawn

Reducing Anemia Through Food Fortification at Scale

Anemia

India
Cohen Global, Ltd.

Recruiting

Subcutaneous Administration of MD-18 in Healthy Subjects

Healthy Volunteers

Israel
Global Neurosciences Institute

Recruiting

Verapamil for Neuroprotection in Stroke

Ischemic Stroke

United States
Global Cell Med

Unknown

Autologous Bone Marrow Transplant in Chronic Insulin Dependent Diabetic Patients

Diabetes Complications | Diabetes Mellitus Progression

Bahamas
Professor Karen I Barnes
Medical Research Council, South Africa; Global Fund

Completed

Pharmacokinetics, Efficacy, Gametocyte Carriage, Birth Outcomes Following Sulfadoxine-pyrimethamine Intermittent Presumptive Treatment in Pregnant Women

Malaria

Mozambique
Professor Karen I Barnes
Medical Research Council, South Africa; Global Fund

Terminated

Artesunate Plus Sulfadoxine-pyrimethamine Pharmacokinetics, Efficacy, Gametocytes Carriage and Birth Outcomes in Pregnant Women With Malaria

Malaria

Mozambique
Global Aesthetics LLC

Recruiting

Assessing the Impact of Botulinum Toxin Type A on Facial Wrinkles: A Comprehensive Clinical Investigation

Wrinkle

United States
Zoe Global Limited

Active, not recruiting

ZOE's Ferment Experiment (ZHS-FE)

Mood | Hunger | Energy

United Kingdom
Global Kinetics Corporation

Active, not recruiting

Evaluation of the Personal KinetiGraph™ (PKG™) to Improve Insight Into Parkinson's Disease Status (APPRISE)

Parkinson Disease

United States
Aspen Global Incorporated

Terminated

Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Argatroban (HITSOVA)

Heparin-induced Thrombocytopenia

United States, Bosnia and Herzegovina, Canada, France, Germany, Italy, Poland, Russian Federation, Serbia
Global Kinetics Corporation

Terminated

Utilization of Target Ranges to Treat Parkinson's Disease With the PKG (TARGET-PD)

Parkinson Disease

United States
Global Blood Therapeutics

Completed

Study to Evaluate the Safety and Tolerability of GBT440 Administered to Subjects With IPF

Idiopathic Pulmonary Fibrosis | Hypoxemia

United States
WCCT Global
Vaxart

Completed

Evaluation of Infectivity and Illness of Norwalk GI.1 Virus Lot 001-09NV in the Human Challenge Model

Norovirus Infection

United States
Aspen Global Incorporated

Completed

A Study Comparing the Local Tolerability of Two Subcutaneous Heparins in Healthy Volunteers.

Injection Site Reaction
Global Blood Therapeutics

Completed

An Extension Study to Further Evaluate the Safety, Tolerability of GBT440 in Patients With Sickle Cell Disease Who Participated in the Study GBT440-001

Sickle Cell Disease

United Kingdom
Global Blood Therapeutics

Completed

A Study of the Safety, Blood Levels and Biological Effects of GBT440 in Healthy Subjects and Subjects With Sickle Cell Disease

Sickle Cell Disease | Healthy Subjects

United Kingdom
Global Blood Therapeutics

Completed

Drug Interaction Study of GBT440 With Caffeine, S-warfarin, Omeprazole, and Midazolam in Healthy Subjects

Sickle Cell Disease

United States
MedLogic Global Limited

Completed

Clinical Trial of MedLogic LiquiBand Laparoscopic Versus Dermabond in the Closure of Surgical Incisions

Laparoscopic Surgery

United Kingdom
Global Kinetics Corporation

Recruiting

Personal KinetiGraph® Clinical Validation Study

Parkinson Disease | Movement Disorders

United States
Global Neurosciences Institute

Recruiting

Super-Selective Intraarterial Intracranial Infusion of Bevacizumab (Avastin) for Glioblastoma Multiforme

Glioblastoma Multiforme

United States
ProgenaCare Global, LLC

Active, not recruiting

Efficacy of ProgenaMatrix™ in the Management of DFUs

Diabetic Foot Ulcer

United States
Global Kinetics Corporation

Withdrawn

Utilization of Target Ranges to Treat Persons With Parkinson's Disease by Objective Measurement Using the PKG (TARGET-PwP)

Parkinson Disease
Global Surgery Amsterdam

Completed

From Short-term Surgical Missions Towards Sustainable Partnerships

Global Surgery | Medical Missions

Netherlands
Global Blood Therapeutics

Terminated

Study to Evaluate the Effect of GBT440 Administered to Subjects With IPF on Supplemental Oxygen at Rest (Zephyr)

Idiopathic Pulmonary Fibrosis | Hypoxemia

United Kingdom, United States
Global Blood Therapeutics

Completed

Single-Dose PK Study of GBT440 in Subjects With Renal Impairment

Renal Impairment

United States
Global Blood Therapeutics

Completed

A Single-Dose Relative Bioavailability Study Of GBT440 300 mg Capsules in Healthy Subjects

Sickle Cell Disease

United States
Global Blood Therapeutics

Completed

A Study of the Absorption, Metabolism, and Excretion of GBT440 in Healthy Male Subjects

Anemia, Sickle Cell

United States
IMPULS Endowment Fund

Completed

Czech Pharmaco-epidemiological Study on Disease Modifying Drugs (CPE)

Multiple Sclerosis

Czechia
Institut de Recherche pour le Developpement
United Nations World Food Programme (WFP); UNICEF; Sidaction; Global Fund

Completed

Nutritional Rehabilitation in Senegalese HIV-infected Children and Adolescents (SNAC'S)

HIV/AIDS | Malnutrition
NICHD Global Network for Women's and Children's...
Thomas Jefferson University; Thrasher Research Fund; RTI International

Completed

ASPIRIN: Neurodevelopmental Follow-up Trial

Neurodevelopmental Abnormality

United States, Zambia, Congo, The Democratic Republic of the, India, Pakistan, Guatemala
St. Jude Children's Research Hospital
Eisai Inc.; Medicines for Malaria Venture; Global Health Innovative Technology...

Completed

First-in-Human Study of an Oral Plasmodium Falciparum Plasma Membrane Protein Inhibitor

Malaria

United States
Ministry of Public Health, Democratic Republic...
Centers for Disease Control and Prevention; Global Fund

Active, not recruiting

Test Efficacy Study on the Recommended Antimalarial Drugs in the Democratic Republic of the Congo (TES2022)

Uncomplicated Plasmodium Falciparum Malaria

Congo, The Democratic Republic of the
HAE Global Registry Foundation

Recruiting

Global Registry to Gather Data on Natural History of Patients With Hereditary Angioedema Type I and II (HGR)

Hereditary Angioedema Type I and II

Italy

Clinical Trials Sponsored by Global Fund

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations